Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of fospropofol disodium versus propofol for induction of general anesthesia
ChiCTR-TRC-12002724Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jun 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fospropofol disodium (2 arms), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd. Primary endpoint: Induction success rate within 5 minutes after administration. Started Jun 2011; status: completed.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on ChiCTR-TRC-12002724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002724.